NICE is ‘setting prices too high’ for NHS
February 19, 2015Sales and Marketing ABPI, NHS, NICE, QALY, costs, health, pharma
The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …
Celgene gets FDA licence extension for myeloma drug
February 19, 2015Sales and Marketing Celgene, FDA, Revlimid, lenalidomide, myeloma
The FDA has given Celgene an extended licence for its multiple myeloma drug Revlimid (lenalidomid), to include people who are …
Pharming names new chief scientific officer
February 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharming, perry calais
Dutch biopharma development firm Pharming has named Dr Perry Calias as the company’s chief scientific officer. Calias will have overall …
UK pharma commits at least ‘one code breach a week’
February 18, 2015Medical Communications, Sales and Marketing ABPI, AstraZeneca, Bayer, Eli Lilly, GSK, Novartis, Novo Nordisk, PMCPA, Pfizer, code
Pharma companies commit unethical marketing practices on average more than once a week in the UK academic analysis has found. …
Sanofi enters autoimmune diseases pact with Lead Pharma
February 18, 2015Research and Development, Sales and Marketing Sanofi, autoimmune, biox, lead pharma, psoriasis
Sanofi is to collaborate with Dutch biotech firm Lead Pharma to develop treatments for autoimmune diseases. The companies will work …
£30m drug discovery centres launched to overcome pharma ‘funding fatigue’
February 18, 2015Research and Development, Sales and Marketing Alzheimer’s Research UK, Cambridge, London, Oxford, dementia, funding, pharma
Three new drug discovery institutes will be launched in the UK with a £30 million commitment to fast-track the development …
NICE unveils guidelines to monitor antibiotic prescribing
February 18, 2015Sales and Marketing AMR, Antibiotics, GPs, NHS, NICE, antimicrobials, baker
NICE are asking UK doctors to spy on their colleagues in order to help tackle the growing threat of antimicrobial …
Tonic Life Communications hires three
February 18, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ainsley cooper, alex davies, appointments, elisabeth neal, tonic life communications
Healthcare comms consultancy Tonic Life Communications has added three new senior heads to increase its London team. The news follows …
Cipla sets up new plant in Morocco
February 17, 2015Manufacturing and Production, Sales and Marketing Cooper Pharma, PHI, PHI), Societe Marocaine De Cooperation Pharmaceutique, The Pharmaceutical Institute, cipla. morocco
Indian firm Cipla’s UK subsidiary has entered into a joint venture to establish a stronger presence in Morocco, as it …
Takeda trial hits late-stage buffers
February 17, 2015Research and Development, Sales and Marketing AMG 706, Japan, NSCLC, Takeda, lung cancer, motesanib
Takeda is to scrap an advanced trial of an investigational drug after it failed to show any benefit in survival …
Several board changes at AstraZeneca
February 17, 2015Sales and Marketing AstraZeneca, Bruce Burlington, Cornelia Bargmann, Graham Chipchase, Rudy Markham
AstraZeneca is conducting a boardroom overhaul as it announces non-executive board changes and retirements ahead of its annual meeting in …
New comms director for Royal College of Surgeons
February 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing RCS, royal college of surgeons, simon edwards
The Royal College of Surgeons has promoted Simon Edwards to the position of director of communications. Edwards previously held the …
Hospira launches biosimilar monoclonal antibody
February 16, 2015Research and Development, Sales and Marketing MSD, Merck, Remicade, biosimilar. hospira, inflectra, infliximab
Hospira has won the race to become the first company to launch a biosimilar version of an anti-TNF biologic, after …
Shire delivers record revenues
February 16, 2015Sales and Marketing ADHD, AbbVie, Shire, Viropharma, Vyvanse, intuniv, lialda
Shire has posted strong growth in its full-year results, showing that the company is faring well even after the collapse …
FDA approves Eisai thyroid drug, fast-tracks Novartis heart pill
February 16, 2015Sales and Marketing Eisai, FDA, LCZ696, Lenvima, Novartis, heart, lenvatinib, thyroid
The FDA has approved Eisai’s thyroid cancer drug Lenvima and also granted Novartis heart pill LCZ696 a priority review. Lenvima …
AstraZeneca loses US Pulmicort patent
February 16, 2015Sales and Marketing AstraZeneca, Budesonide Inhalation Suspension, asthma, pulmicourt, respiratory
British drugmaker AstraZeneca has been dealt a blow by the courts in the US, after a district judge ruled its …
Onyx Health appoints account manager
February 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Onyx, dean forbes
UK healthcare marketing communications firm experts Onyx Health have hired Dean Forbes to develop their marketing, PR and branding services. …
Big Data has yet to hit the big time
February 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Big Data, chris poole, data, development, mark thornton
Big data has taken quite a knocking over the past year. First, from some sceptics who have warned big data …
TiGenix and Lonza partner on stem cell manufacturing
February 13, 2015Manufacturing and Production, Sales and Marketing Crohn’s disease, Lonza, Stem cells, TiGenix, crohn's disease, eascs, manufacturing, spa
Stem cell therapy developer TiGenix has enlisted the help of biologics manufacturer Lonza to produce its medicine Cx601 for late-stage …
Hormone replacement therapy elevates ovarian cancer risk
February 13, 2015Research and Development, Sales and Marketing Cancer, HRT, Lancet, Oxford, oncology, ovarian
According to a new study women who undergo hormone replacement therapy nearly double their risk of developing ovarian cancer. Findings …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
